Platelet Accumulation on Fibrin-coated Polyethylene: Role of Platelet Activation and Factor XIII

Summary

Platelet accumulation on small- and medium-calibre vascular grafts plays a significant role in graft occlusion. We examined platelet accumulation on the surface of fibrin-coated polyethylene tubing (internal diameter 0.17 cm) during 10 min of flow (l0ml/min) at high wall shear rate (764 s^-1). Washed platelets labelled with ⁵¹Cr were resuspended in Tyrode solution containing albumin, apyrase and red blood cells (hematocrit 40%). When the thrombin that was used to form the fibrin-coated surface was inactivated with FPRCH₂C1 before perfusion of the tubes with the platelet:red blood cell suspension, the accumulation of platelets was 59,840 ± 27,960 platelets per mm², whereas accumulation on fibrin with residual active thrombin was 316,750 ± 32,560 platelets per mm² (n = 4). When the fibrin on the surface was cross-linked by including recombinant factor XIII (rFXIII) in the fibrinogen solution used to prepare the fibrin-coated surface, platelet accumulation, after thrombin neutralization, was reduced by the cross-linking from 46,974 ± 9702 to 36,818 ± 7964 platelets per mm² (n = 12, p <0.01). Platelet accumulation on tubes coated with D-dimer was ten times less than on tubes coated with D-domain; this finding also supports the observation that cross-linking of fibrin with the formation of γ-γ dimers reduces platelet accumulation on the fibrin-coated surface. Thrombin-activated platelets themselves were shown to cross-link fibrin when they had adhered to it during perfusion, or in a static system in which thrombin was used to form clots from FXIII-free fibrinogen in the presence of platelets. Thus, cross-linking of fibrin by FXIII in plasma or from platelets probably decreases the reactivity of the fibrin-containing thrombi to platelets by altering the lysine residue at or near the platelet-binding site of each of the γ-chains of the fibrinogen which was converted into the fibrin of these thrombi.

• References

• 1 Nichter LS, Bindiger A. Improving micrograft patency. Microsurgery 1988; 9: 235-241
• 2 Johnson PC. Platelet-mediated thrombosis in microvascular surgery: new knowledge and strategies. Plast Reconstr Surg 1990; 86: 359-367
• 3 Salzman EW, Merrill EW. Interaction of blood with artificial surfaces. In: Hemostasis and Thrombosis. Basic Principles and Clinical Practice, 2nd edition Colman RW, Hirsh J, Marder VJ, Salzman EW. eds JB Lippincott; Philadelphia, PA: 1987. pp 1335-1347
• 4 Forbes CD, Courtney JM. Thrombosis and artificial surfaces. In: Haemostasis and Thrombosis. Vol 2, 3rd edition Bloom AL, Forbes CD, Thomas DP, Tuddenham EG D. eds Churchill Livingstone; Edinburgh: 1994. pp 1301-1324
• 5 Packham MA. The behavior of platelets at foreign surfaces. Proc Soc Exp Biol Med 1988; 189: 261-274
• 6 Ward CA, Stanga D. Biological activity of fibrinogen adsorbed on synthetic materials. J Colloid Interface Sci 1986; 114: 323-329
• 7 Chiu YL, Chou YL, Jen CJ. Platelet deposition onto fibrin-coated surfaces under flow conditions. Blood Cells 1988; 13: 437-447
• 8 Francis CW, Markham REJ, Marder VJ. Demonstration of in situ fibrin degradation in pathologic thrombi. Blood 1984; 63: 1216-1224
• 9 Kettner C, Shaw E. D-Phe-Pro-ArgCH₂Cl -a selective affinity label for thrombin. Thromb Res 1979; 14: 969-973
• 10 Hanson SR, Harker LA. Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone. Proc Natl Acad Sci USA 1988; 85: 3184-3188
• 11 Hangtan RR, Hindriks G, Taylor RG, Sixma JJ, de Groot PG. Glycoprotein Ib, von Willebrand factor, and glycoprotein IIb : IIIa are all involved in platelet adhesion to fibrin in flowing whole blood. Blood 1990; 76: 345-353
• 12 Loscalzo J, Inbal A, Handin RI. von Willebrand protein facilitates platelet incorporation in polymerizing fibrin. J Clin Invest 1986; 78: 1112-1119
• 13 Tuszynski GP, Kornecki E, Cierniewski C, Knight LC, Koshy A, Srivastava S, Niewiarowski S, Walsh PN. Association of fibrin with the platelet cytoskeleton. J Biol Chem 1984; 259: 5247-5254
• 14 Coller BS. Interaction of normal, thrombasthenic, and Bemard-Soulier platelets with immobilized fibrinogen: defective platelet-fibrinogen interaction in thrombasthenia. Blood 1980; 55: 169-178
• 15 Kieffer N, Fitzgerald LA, Wolf D, Cheresh DA, Phillips DR. Adhesive properties of the β₃ integrins: comparison of GP IIb-IIIa and the vitronectin receptor individually expressed in human melanoma cells. J Cell Biol 1991; 113: 451-461
• 16 Savage B, Ruggeri ZM. Selective recognition of adhesive sites in surface- bound fibrinogen by glycoprotein IIb-IIIa on nonactivated platelets. J Biol Chem 1991; 266: 11227-11233
• 17 Gartner TK, Amrani DL, Derrick JM, Kirschbaum NE, Matsueda GR, Taylor DB. Characterization of adhesion of “resting” and stimulated platelets to fibrinogen and its fragments. Thromb Res 1993; 71: 47-60
• 18 Farrell DH, Thiagarajan P. Binding of recombinant fibrinogen mutants to platelets. J Biol Chem 1994; 269: 226-231
• 19 Hantgan RR, Taylor RG, Lewis JC. Platelets interact with fibrin only after activation. Blood 1985; 65: 1299-1311
• 20 Jen CJ, Lin JS. Direct observation of platelet adhesion to fibrinogen- and fibrin-coated surfaces. Am J Physiol 1991; 261: H1457-H1463
• 21 Jen CJ, Hu SJ. Direct platelet-fibrin interaction that does not require platelet activation. Am J Physiol 1987; 253: H745-H750
• 22 Rubens F, Brash J, Weitz J, Kinlough-Rathbone R. Interactions of thermally denatured fibrinogen on polyethylene with plasma proteins and platelets. J Biomed Mat Res 1992; 26: 1651-1663
• 23 Chen R, Doolittle RF. γ-γ Cross-linking sites in human and bovine fibrin. Biochemistry 1971; 10: 4486-4491
• 24 Marder VJ, Francis CW. Plasmin degradation of cross-linked fibrin. Ann NY Acad Sci 1983; 408: 397-406
• 25 McManama G, Lindon JN, Kloczewiak M, Smith MA, Ware JA, Hawiger J, Merrill EW, Salzman EW. Platelet aggregation by fibrinogen polymers crosslinked across the E domain. Blood 1986; 68: 363-371
• 26 Kinlough-Rathbone RL, Packham MA, Mustard JF. Platelet aggregation. In: Methods in Hematology. Measurements of Platelet Function. Harker LA, Zimmerman TS. eds Churchill Livingstone; Edinburgh: 1983. pp 64-91
• 27 Bishop PD, Teller DC, Smith RA, Lasser GW, Gilbert T, Seale RL. Expression, purification, and characterization of human factor XIII in Saccharomyces cerevisiae. Biochemistry 1990; 29: 1861-1869
• 28 Straughn WIII, Wagner RH. A simple method for preparing fibrinogen. Thrombos Diathes haemorrh (Stuttg) 1966; 16: 198-206
• 29 Lawrie JS, Ross J, Kemp GD. Purification of fibrinogen and the separation of its degradation products in the presence of calcium ions. Biochem Soc Trans 1979; 7: 693-694
• 30 Delvos U, Müller-Berghaus G. Influence of the fibrin(ogen) degradation product fragment D on the monolayer integrity of cultured vascular endothelial cells. Haemostasis 1988; 18: 99-105
• 31 Haverkate F, Timan G. Protective effect of calcium in the plasmin degradation of fibrinogen and fibrin fragments D. Thromb Res 1977; 10: 803-812
• 32 Haverkate F, Timan G, Nieuwenhuizen W. Anticlotting properties of fragments D from human fibrinogen and fibrin. Eur J Clin Invest 1979; 9: 253-255
• 33 Brenner B, Francis CW, Marder VJ. The role of soluble cross-linked fibrin in D dimer immunoreactivity of plasmic digests. J Lab Clin Med 1989; 113: 682-688
• 34 Tuszynski GP, Knight L, Pipemo JR, Walsh PN. A rapid method for removal of [¹²⁵I]iodide following iodination of protein solutions. Analyt Biochem 1980; 106: 118-122
• 35 Mustard JF, Kinlough-Rathbone RL, Packham MA. Isolation of human platelets from plasma. In: Methods in Enzymology. Platelets: Receptors, Adhesion, Secretion, Vol.169, Part A Hawiger JJ. ed Academic Press; New York: 1989. pp 3-11
• 36 Cazenave J-P, Blondowska D, Richardson M, Kinlough-Rathbone RL, Packham MA, Mustard JF. Quantitative radioisotopic measurement and scanning electron microscopic study of platelet adherence to a collagen- coated surface and to subendothelium with a rotating probe device. J Lab Clin Med 1979; 93: 60-70
• 37 Turitto VT, Baumgartner HR. Platelet-surface interactions. In: Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 2nd edition. Colman RW, Hirsh J, Marder VJ, Salzman EW. eds Lippincott; Philadelphia, PA: 1987. pp 555-571
• 38 Brash JL, Brophy JM, Feuerstein IA. Adhesion of platelets to artificial surfaces: effect of red cells. J Biomed Mater Res 1976; 10: 429-443
• 39 Bom GV R, Bergqvist D, Arfors K-E. Evidence for inhibition of platelet activation in blood by a drug effect on erythrocytes. Nature 1976; 259: 233-235
• 40 Niewiarowski S, Regoeczi ED, Stewart GJ, Senyi AF, Mustard JF. Platelet interaction with polymerizing fibrin. J Clin Invest 1972; 51: 685-700
• 41 Packham MA. Role of platelets in thrombosis and hemostasis. Can J Physiol Pharmacol 1994; 72: 278-284
• 42 Cattaneo M, Canciani MT, Lecchi A, Kinlough-Rathbone RL, Packham MA, Mannucci PM, Mustard JF. Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates. Blood 1990; 75: 1081-1086
• 43 Kinlough-Rathbone RL, Packham MA, Perry DW, Mustard JF, Cattaneo M. Lack of stability of aggregates after thrombin-induced reaggregation of thrombin-degranulated human platelets. Thromb Haemost 1992; 67: 453-457
• 44 Hansen MS. Fibronectin and coagulation factor XIII increases blood platelet adhesion to fibrin. Thromb Res 1984; 34: 551-556
• 45 Silverstein RL, Leung LL, Nachman RL. Thrombospondin: A versatile multifunctional glycoprotein. Arteriosclerosis 1987; 6: 245-253
• 46 Kreager JA, Devine DV, Greenberg CS. Cytofluorometric identification of plasmin-sensitive factor XHIa binding to platelets. Thromb Haemost 1988; 60: 88-93
• 47 Lorand L, Weissmann LB, Epel DL, Bruner-Lorand J. Role of the intrinsic transglutaminase in the Ca²⁺-mediated crosslinking of erythrocyte proteins. Proc Natl Acad Sci USA 1976; 73: 4479-4481
• 48 Joist JH, Niewiarowski S. Retention of platelet fibrin stabilizing factor during the platelet release reaction and clot retraction. Thrombos Diathes haemorrh (Stuttg) 1973; 29: 679-683
• 49 Francis CW, Marder VJ. Rapid formation of large molecular weight α-polymers in cross-linked fibrin induced by high factor XIII concentrations. J Clin Invest 1987; 80: 1459-1465
• 50 Plow EF, Srouji AH, Meyer D, Marguerie G, Ginsberg MH. Evidence that three adhesive proteins interact with a common recognition site on activated platelets. J Biol Chem 1984; 259: 5388-5391
• 51 Ichinose A. The physiology and biochemistry of factor XIII. In: Haemostasis and Thrombosis, Vol 1, 3rd edition. Bloom AL, Forbes CD, Thomas DP, Tuddenham EG D. eds Churchill Livingstone; Edinburgh: 1994. pp 531-546
• 52 Hatton MW C, Moar SL, Richardson M. Enhanced binding of fibrinogen by the subendothelium after treatment of the rabbit aorta with thrombin. J Lab Clin Med 1990; 115: 356-364
• 53 Smith EB, Keen GA, Grant A, Stirk C. Fate of fibrinogen in human arterial intima. Arteriosclerosis 1990; 10: 263-275